米国市場銘柄情報

SHPH Shuttle Pharmaceuticals Hold

銘柄追加

0.385
-0.014-3.56%

終値 04/26 16:00 ET

646.60万時価総額-875直近PER

Shuttle Pharmaceuticals Holdに関するコメント

ログインコメントを投稿

Biff

01/08 22:06

$Shuttle Pharmaceuticals Hold(SHPH.US)$ I've been waiting on this. Very nice. But, only phase 2 so far.

Trytosaveabit

01/08 22:03

News

$Shuttle Pharmaceuticals Hold(SHPH.US)$ Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
3 MINUTES AGO, 9:00 AM EST

Trytosaveabit

2023/12/28 05:03

$Shuttle Pharmaceuticals Hold(SHPH.US)$ Dont see the IND approval from FDA yet? but it should have a answer before EOY?

Trytosaveabit

2023/12/28 05:01

BOOM

$Shuttle Pharmaceuticals Hold(SHPH.US)$

Trytosaveabit

2023/10/31 21:12

$Shuttle Pharmaceuticals Hold(SHPH.US)$

Alvinnnnnnngenius

2023/10/31 21:01

$Shuttle Pharmaceuticals Hold(SHPH.US)$ Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement

Trytosaveabit

2023/10/31 05:26

Update

$Shuttle Pharmaceuticals Hold(SHPH.US)$ On October 24, 2023, Shuttle Pharmaceuticals Entered Into An Exclusive Licensing Agreement With Georgetown University

JESSE JAMES8832

2023/10/25 20:25

News $cybn

$サイビン(CYBN.US)$$T2バイオシステムズ(TTOO.US)$$ヴァージン・ギャラクティック・ホールディングス(SPCE.US)$$ファラデイ・フューチャー・インテリジェント・エレクトリック(FFIE.US)$$ニューロセンス・セラピューティクス(NRSN.US)$$ライオット・プラットフォームズ(RIOT.US)$$Shuttle Pharmaceuticals Hold(SHPH.US)$$MINDSET PHARMA INC(MSSTF.US)$

Biff

2023/10/21 10:14

$Shuttle Pharmaceuticals Hold(SHPH.US)$ Nice news

Biff

2023/10/19 22:47

$Shuttle Pharmaceuticals Hold(SHPH.US)$ It's coming soon
The company said that the FDA's positive feedback and guidance on its Chemistry, Manufacturing and Controls, and clinical protocol design for Ropidoxuridine provides a pathway to IND application submission in the fourth quarter of 2023 to initiate the Phase 2 clinical trial.
Ropidoxuridine is Shuttle's lead candidate of radiation sensitizer for use in combination with radiation therapy to treat brain tumors, or glioblastoma, a deadly malignan...

Weight-loss drugmakers report strong earnings: Boon or bane?

まだコメントはありません

分析

アナリスト評価

データなし

目標株価

データなし

ホット

米国株

総合人気